Corporate Profile for Biopool International Inc., dated Aug. 29, 1997.

--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-

Published Date:   Aug. 29, 1997

Company Name:     Biopool International Inc.

Address:          6025 Nicolle St.
                  Ventura, Calif. 93003

Main Telephone
 Number:          805/654-0643

Chief Executive
 Officer:         Michael D. Bick

Chief Financial
 Officer:         Robert K. Foote

Trading Symbol/
 Exchange:        BIPL (Nasdaq)

Industry:         Medical devices

Market Makers:    Mayer & Schweitzer, Knight Securities, Nash
                  Weiss, Herzog Heine Geduld, Wien Securities,
                  Sherwood Secs., M.H. Meyerson & Co., Wilson-Davis
                  & Co., Troster Singer Corp., Rocky Mountain Secs.

Company description:

Biopool International Inc. develops, manufactures and markets a
full range of in vitro diagnostic blood test kits used to assess and
diagnose disorders of blood coagulation, thrombotic risk factors,
fibrinolysis, platelet function and the vascular system.

The company also provides specialty chemistry controls used to
monitor and measure the presence of drugs of abuse and
immunohematology products used in routine ABO and Rh blood grouping
and to screen for rare antibodies and antigens in blood.

Incorporated in Delaware in 1987 and with headquarters in
Ventura, Calif., Biopool has two subsidiaries, Biopool AB (Sweden)
and Biopool Canada, and a newly acquired division, BCA, located in
West Chester, Pa.  The acquisition of this division from Organon
Teknika Corp. in January 1997 effectively doubled the size of the
company.

Biopool's complete line of more than 150 FDA-approved products
is sold to hospitals, clinical laboratories, commercial reference
laboratories, blood centers and biomedical research institutions on
a worldwide basis.

In addition to selling its products through distributors in more
than 40 countries, Biopool also develops and manufactures test kits
under private label and OEM agreements with such companies as Dade
International, Instrumentation Laboratory, Ortho Diagnostic Systems
(a division of Johnson & Johnson) and Sigma Diagnostics
(Sigma/Aldrich).


STOCK DATA:

Symbol:                 BIPL
FYE:                    12/31
52-Week High/Low        $3.81 - $1.93
30-Day Avg. Daily
  Vol. (a) :            27,000
Float:                  $5.1 million (approx.)
Shares Outstanding:     8,621,248
Market Cap (a) :        $19.4 million

(a)  Aug. 25, 1997.


STATEMENT OF INCOME

(in thousands, except per-share data)

For Years Ended Dec. 31,      1996      1995     1994

Sales                        $8,020    $6,662   $5,527
Income before taxes           1,180       261      816
Net income                    1,295       141      705
Earnings per share           $  .15    $  .02   $  .09

CONTACT: Bipool International Inc.